Effect of Left Ventricular Assist Device Infection on Post-transplant Outcomes

被引:61
|
作者
Schulman, Allison R. [1 ]
Martens, Timothy P. [1 ]
Russo, Mark J. [1 ]
Christos, Paul J. [2 ]
Gordon, Rachel J. [1 ]
Lowy, Franklin D. [1 ]
Oz, Mehmet C. [1 ]
Naka, Yoshifumi [1 ]
机构
[1] Columbia Univ, Med Ctr, Div Cardiothorac Surg, New York, NY 10032 USA
[2] Cornell Univ, Weill Med Coll, Dept Publ Hlth, Div Biostat & Epidemiol, New York, NY 10021 USA
来源
关键词
IMPLANTATION; SUPPORT; HYPOGAMMAGLOBULINEMIA; TRANSPLANTATION; PREVENTION; EXPERIENCE; MANAGEMENT; SURFACE; BRIDGE; IMPACT;
D O I
10.1016/j.healun.2008.12.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: in this study, we sought to confirm which types of device-related infections impact bridge-to-transplant rates. We also aimed to determine the effect of device-related infections on post-transplant survival and post-transplant infection. Methods: We retrospectively reviewed paper and electronic medical records for 149 patients undergoing left ventricular assist device (LVAD) implantation as a bridge to transplantation at the Columbia Presbyterian Medical Center between 2000 and 2006. The primary outcome measures were survival to transplantation, post-transplant infection and post-transplant survival. Results: Patients with sepsis were less likely to be successfully bridged to cardiac transplantation (7 of 22 vs 103 of 127, 31.8% vs 81.1%, p = 0.01). However, if transplanted, their survival rates at 1 year were not decreased (6 of 7 vs 85 of 103, 85.7% vs 82.5%, p = 1.00). No other pre-transplant device-related infection affected post-transplant survival at 1 year (22 of 27 vs 69 of 83, 81.5% vs 83.1%, P = 1.00). Pre-transplant drive-fine infections predicted post-transplant: infection in former drive-line or pocket sites (11 of 16 vs 14 of 94, 68.8% vs 14.9%, p = 0.01) and increased overall post-transplant hospital length of stay (16 vs 19 days, p = 0.04). They did not, however, affect post-transplant survival at I year (22 of 25 vs 69 of 85, 88% vs 81.2%, p = 0.56). Conclusions: Although survival to transplantation was diminished in LVAD patients with sepsis, if successfully transplanted, post-transplant survival was unaffected. Patients with local device infections and signs of early sepsis may warrant evaluation for urgent transplantation. A pre-transplant drive-line infection was associated with post-transplant infection in either the former pocket or drive-line site, and increased overall length of stay, but it did not decrease post-transplant survival. J Heart Lung Transplant 2009;28:237-42. Copyright (C) 2009 by the International Society for Heart and Lung Transplantation.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 50 条
  • [41] Outcomes Following Left Ventricular Assist Device Exchange: Focus on the Impacts of Device Infection
    Yost, Gardner
    Coyle, Laura
    Gallagher, Colleen
    Cotts, William
    Pappas, Patroklos
    Tatooles, Antone
    ASAIO JOURNAL, 2021, 67 (06) : 642 - 649
  • [42] Less Invasive Left Ventricular Assist Device Implantation-5-Year Survival and Post Transplant Outcomes
    Riebandt, J.
    Moayedifar, R.
    Wiedemann, D.
    Schloeglhofer, T.
    Dimitrov, K.
    Rajek, A.
    Laufer, G.
    Zimpfer, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S480 - S480
  • [43] Association of Infections in Patients Supported with Left Ventricular Assist Device with Vasoplegia and Post-Cardiac Transplant Outcomes
    Halista, Michael
    Parikh, Aditya
    Mancini, Donna
    Mitter, Sumeet
    Barghash, Maya
    Trivieri, Maria
    Contreras, Johanna
    Taimur, Sarah
    Roldan, Julie
    Murphy, Joseph
    Pawale, Amit
    Anyanwu, Anelechi
    Pinney, Sean
    Moss, Noah
    Lala, Anuradha
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S175 - S175
  • [44] Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices
    Ventura, Pere A.
    Alharethi, Rami
    Budge, Deborah
    Reid, Bruce B.
    Horne, Benjamin D.
    Mason, Nathan O.
    Stoker, Sandi
    Caine, William T.
    Rasmusson, Brad
    Doty, John
    Clayson, Stephen E.
    Kfoury, Abdallah G.
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : E390 - E395
  • [45] Single Center Outcomes Of Right Ventricular Assist Devices Post-Left Ventricular Assist Device Implantation
    Kochar, Kirpal
    Vishnevsky, Alec
    Massey, Howard
    Tchantchaleishvili, Vakhtang
    Rame, J. Eduardo
    Alvarez, Rene
    Gibson, Gregory
    Brailovsky, Yevgeniy
    Rajapreyar, Indranee
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 212 - 213
  • [46] Heart transplant and left ventricular assist device costs
    Bostic, RR
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11): : 1997 - 1998
  • [47] Heart transplant and left ventricular assist device costs
    DiGiorgi, PL
    Reel, MS
    Thornton, B
    Burton, E
    Naka, Y
    Oz, MC
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : 200 - 204
  • [48] The Effect of Ventricular Assist Devices on Long-Term Post-Transplant Outcomes: A Systematic Review of Observational Studies
    Alba, A. C.
    McDonald, M.
    Rao, V.
    Ross, H. J.
    Delgado, D. H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S124 - S124
  • [49] The effect of ventricular assist devices on long-term post-transplant outcomes: a systematic review of observational studies
    Alba, Ana C.
    McDonald, Michael
    Rao, Vivek
    Ross, Heather J.
    Delgado, Diego H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (07) : 785 - 795
  • [50] Outcomes of COVID-19 Infection in Patients with Left Ventricular Assist Device
    Bhattal, G. K.
    Alom, M. K.
    Kabra, N.
    Rawitscher, D.
    George, T.
    Afzal, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S230 - S230